Author

T. V. Tran

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:non-human primate· 1 Research Focus:phylogenetics / evolution· 1

Frequent Co-Authors

A. T. L. Truong· 1 shared B. May· 1 shared B. V. Nguyen· 1 shared C. T. Truong· 1 shared D. K. Nguyen· 1 shared D. L. Phan· 1 shared H. Khong· 1 shared H. Q. H. Hua· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPlant Biology

A. T. L. Truong

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular Phylogeny and Cryptic Morphology: A Combined Approach to Taxonomic Novelties in Polycarpaea (Caryophyllaceae) from Vietnam

T. V. Tran, T. T. Hoang, L. B. Le, N. T. K. Le, M. T. A. Nguyen, A. T. L. Truong, N. T. Tran, V. T. Tran, S. V. Le, K. T. Duong, K. V. B. Hoang, T. N. Le, B. V. Nguyen

The paper describes three new Polycarpaea species from Vietnam using molecular and morphological data and reports new insights into the systematic positions of seven other species.

bioRxiv · Mar 18, 2024 · PreprintPlant Biology

PRE-CLINICAL IMMUNE RESPONSE AND SAFETY EVALUATION OF THE PROTEIN SUBUNIT VACCINE NANOCOVAX FOR COVID-19

T. N. M. Tran, B. May, T. T. Ung, M. K. Nguyen, T. T. Nguyen, V. L. Dinh, T. V. Tran, H. Khong, T. T. Nguyen, H. Q. H. Hua, V. A. Nguyen, T. P. Ha, D. L. Phan, T. A. Nguyen, T. N. Bui, , M. S. Do

This study evaluates the immune response and safety of the protein subunit vaccine Nanocovax in animal models, showing high immunogenicity and no adverse effects.

bioRxiv · Jul 20, 2021 · PreprintImmunology